共 50 条
- [41] Multimodality approaches in breast cancer: What have we learned? [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S301 - S301
- [42] Thalidomide in lung cancer therapy—what have we learned? [J]. Nature Reviews Clinical Oncology, 2010, 7 : 134 - 135
- [43] The graying of testis cancer patients: What have we learned? [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4341 - 4343
- [44] What we have learned about cachexia in gastrointestinal cancer [J]. DIGESTIVE DISEASES, 2003, 21 (03) : 198 - 213
- [45] Hereditary ovarian and breast cancer: what have we learned? [J]. ANNALS OF ONCOLOGY, 2013, 24 : 83 - 95
- [46] Histone Deacetylase Inhibitors in Cancer: What Have We Learned? [J]. CANCER, 2015, 121 (08) : 1164 - 1167
- [48] Genomic approaches in oral cancer: What have we learned? [J]. ORAL ONCOLOGY, 2005, 1 (01) : 59 - 59